What question did this study set out to answer?

To discuss the management of recurrent hyperhaemolysis syndrome in a patient with sickle cell disease.

December 8, 2025Blood

IVIG successfully halts a recurrent hyperhaemolysis syndrome in a young patient with sickle cell crisis

View Full Paper

Ask AI

Bookmark

Authors

Case report shows IVIG and steroids increase hemoglobin in a young patient with sickle cell crisis, suggesting effective treatment options.

To discuss the management of recurrent hyperhaemolysis syndrome in a patient with sickle cell disease.
Case report of a 27-year-old male with recurrent hyperhaemolysis syndrome
Administration of IVIG 1g/kg for 5 days and methylprednisolone
Monitoring of hemoglobin levels and patient response to treatment.
Patient's hemoglobin increased from 4.8 to 7.3 mg/dl after IVIG treatment
Reticulocytes rose from 11% to 27% post-transfusion
Treatment suggested IVIG as a valuable option in managing hyperhaemolysis syndrome.

Rajesh et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Case report shows IVIG and steroids increase hemoglobin in a young patient with sickle cell crisis, suggesting effective treatment options.